AzTrials
AzTrials

Bankart LesionBANKARTNCT03315819

Anterior Capsulo-labral Reinsertion by Arthroscopic Approach Versus Immobilization

A study testing Bankart repair and Immobilization interne rotation in people with Bankart Lesion, run by University Hospital, Lille at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The risk of recurrence and chronic instability after an initial episode of anterior glenohumeral dislocation is high, the risk is higher the younger the patient is. Most patients with recurrences develop this instability during the first 2 years. Read more about this study

Who is it for?
Ages 18 to 25 years
Conditions the study is for
Bankart Lesion
What is being tested?
Bankart repair and Immobilization interne rotation
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteFrance
Study dates
27 Mar 2014to 26 Mar 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 25 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Patients with inclusive on the day of dislocation.
  • First episode of anterior glenohumeral dislocation without associated humeral fracture confirmed by a standard radiograph.

Who cannot join

  • Dislocation without trauma, in a context of hyper laxity with a Beighton score ≥4 / 97.8. In these patients post-dislocation MRI was performed in the Robinson study, which found no capsulo-labral lesion.
  • Bone glenoid defect> 25% at the scanner (Bony Bankart).
  • Delay greater than 15 days between luxation and surgical treatment
  • Against indication to anesthesia
  • Pregnant or nursing women

Trial locations and contacts

1 site in 1 country.

France1 site
  • Hôpital Roger Salengro

    Lille, 59000

Other trials in France

About this study

Official title: First Episode of Anterior Glenohumeral Dislocation in Adult Patients Under 25 Years of Age: Anterior Capsulo-labral Reinsertion by Arthroscopic Approach Versus Immobilization "

The risk of recurrence and chronic instability after an initial episode of anterior glenohumeral dislocation is high, the risk is higher the younger the patient is.

Most patients with recurrences develop this instability during the first 2 years.

Read more

Several studies have shown that an initial arthroscopic surgical treatment (Bankart intervention) decreased the risk of recurrence and therefore of chronic instability, but this attitude is not usual in France and none randomized study comparing intervention of arthroscopic Bankart and immobilization was published by a French team.

The primary objective was to evaluate at 2 years the efficacy on the rate of recurrent instability of the first-line arthroscopic repair of prior capsulo-labral lesions compared to conservative treatment by immobilization for patients under 25 years having an initial episode of anterior glenohumeral dislocation

Material and method : We conducted a randomized controlled, open-label, parallel-group study (conservative treatment group by immobilizing VS surgical treatment group) in patients aged 18 to 25 with anterior glenohumeral primo luxation. Patients were clinically reassessed at 2 years with functional scores (WOSI, DuplayWalch, DASH), mobility and instability recurrence.

Hypothesis: reduction of the recurrence rate in the surgically treated group

Conditions
Bankart Lesion
Being tested
Bankart repair, Immobilization interne rotation
Keywords
glenohumeral dislocation, Arthroscopic, capsular lesions
Medical subject headings
Bankart Lesions, Shoulder Dislocation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Bankart repairProcedure or surgery

    Arthroscopic repair of anterior capsulo-labral lesions using the Bankart technique.

  • Immobilization interne rotationProcedure or surgery

    Immobilisation in rotation Internal (Dujarrier) 3 weeks then rehabilitation

Study groups in NCT03315819
Study groupRoleWhat they receive
Bankart repairExperimentalArthroscopic repair of anterior capsulo-labral lesions using the Bankart technique. The procedure must be performed within 15 days of dislocation.
Receives: Procedure: Bankart repair
Immobilization interne rotationActive comparatorImmobilization of the shoulder during 3 weeks
Receives: Procedure: Immobilization interne rotation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of occurrence of a recurrence during the follow-up period of 2 years

    Measured: at 2 years

Secondary outcomes (9)
  1. Number of recidivism of dislocation with the necessity of reduction by a third person

    Measured: at 3 months, 6 months, 1 years and 2 years

  2. number of episodes of subluxations reported by the patient at the interview

    Measured: at 3 months, 6 months, 1 years and 2 years

  3. Goniometer measurement of the angle in the ankle joint

    Measured: at 3 months, 6 months, 1 years and 2 years

  4. Walch Duplay Score

    Auto questionnaire designed to measure the impact of shoulder instability, activity, pain mobility.total point up to 100 : excellent, good, medium, poor

    Measured: at 3 months, 6 months, 1 years and 2 years

  5. Disabilities of the Arm, Shoulder and Hand (DASH) Score

    Auto questionnaire designed to measure the quality of life of patients.

    Measured: at 3 months, 6 months, 1 years and 2 years

  6. Western Ontario Shoulder Instability (WOSI) Score.

    Auto questionnaire designed to measure the impact of shoulder instability on the quality of life of patients. percentage of lifestyle, emotion, physical symptome.

    Measured: at 3 months, 6 months, 1 years and 2 years

  7. Likert Scale

    Overall patient satisfaction

    Measured: at 2 years

  8. The duration of work stoppage

    Measured: at 2 years

  9. Time lapse - resumption of sports activities and level of sport practiced

    Measured: At 6 months, 1 years and 2 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Oct 2017
  2. Study start27 Mar 2014
  3. Primary completion26 Mar 2019
  4. Study completion26 Mar 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03315819
Sponsor's protocol ID
2013_30
Other IDs
2013-A01720-45
Acronym
BANKART
Status last verified
Feb 2019
First submitted
16 Oct 2017
Last updated
22 Dec 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Pouges C, Hardy A, Vervoort T, Amouyel T, Duriez P, Lalanne C, Szymanski C, Deken V, Chantelot C, Upex P, Maynou C. Arthroscopic Bankart Repair Versus Immobilization for First Episode of Anterior Shoulder Dislocation Before the Age of 25: A Randomized Controlled Trial. Am J Sports Med. 2021 Apr;49(5):1166-1174. doi: 10.1177/0363546521996381. Epub 2021 Mar 11.

    PubMed 33705240
  • Pouges C, Boutry M, Maynou C, Chantelot C, Vervoort T, Amouyel T, Lalanne C, Malandri-Ghipponi P. Arthroscopic Bankart Repair Versus Immobilization for a First Episode of an Anterior Shoulder Dislocation Before the Age of 25 Years: A Randomized Controlled Trial With 6-Year Follow-up. Am J Sports Med. 2025 Aug;53(10):2289-2297. doi: 10.1177/03635465251350151. Epub 2025 Jul 2.

    PubMed 40605377

Questions about this trial

What is this clinical trial studying?

A study testing Bankart repair and Immobilization interne rotation in people with Bankart Lesion, run by University Hospital, Lille at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of occurrence of a recurrence during the follow-up period of 2 years (time frame: at 2 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03315819, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in